TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/19 20:11 | 8/3/19 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chondros Dimitrios | CA | O | SVP,Chie | S | -22 | 16.70 | 0 | -1 | -3 | 39 | D | ||||||||||||||
6/3/19 17:22 | 6/1/19 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Chondros Dimitrios | CA | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 2 | 5 | 40 | D | ||||||||||||||
2/22/19 19:04 | 2/22/19 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Chondros Dimitrios | CA | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 4 | 11 | 39 | D | ||||||||||||||
2/20/19 20:10 | 2/3/19 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Chondros Dimitrios | CA | O | SVP,Chie | S.a | -42 | 16.41 | 0 | -3 | -7 | 32 | D | ||||||||||||||
2/15/19 17:36 | 2/14/19 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Chondros Dimitrios | CA | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 7 | 23 | 36 | D | ||||||||||||||
6/5/18 16:06 | 6/1/18 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Chondros Dimitrios | CA | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 2 | 6 | 35 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |